Form D · Other Health Care
Dorsata, Inc.
Arlington, VA · CIK 0001750917
Offering snapshot reported Apr 14, 2020 · SEC filing
- Reported sold
- $2.41M Offering amount: $2.41M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 18, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2020 | Initial | $2,411,447 | No comparison | 11 | SEC filing |
| Apr 14, 2020 | Initial | $2,230,219 | No comparison | 13 | SEC filing |
| Apr 14, 2020 | Initial | $5,240,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-364927
Preferred Stock can convert to the underlying shares of Common Stock.
Source: Form D, filed Apr 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David S. Fairbrothers | Director, Executive |
| Peter Hotz | Director |
| Mark Kolb | Director, Executive |
| Miles Reidy | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2231 Crystal Drive, 10 Th Floor
Arlington, VA, 22202
Arlington, VA, 22202